skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Artigos de Jornal remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
FDA Approves New Antibiotic for Three Indications; Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia
FDA Approves New Antibiotic for Three Indications; Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

FDA Approves New Antibiotic for Three Indications; Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia

Physician's Briefings, 2024-04-08

HealthDay

Sem texto completo

Citações Citado por
2
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection; Early oral antimicrobial therapy noninferior to intravenous standard therapy for low-risk bloodstream infection
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection; Early oral antimicrobial therapy noninferior to intravenous standard therapy for low-risk bloodstream infection
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection; Early oral antimicrobial therapy noninferior to intravenous standard therapy for low-risk bloodstream infection

Physician's Briefings, 2024-01-26

HealthDay

Sem texto completo

Citações Citado por
3
NEW UNDERSTANDING OF 'SUPERANTIGENS' COULD LEAD TO IMPROVED STAPH INFECTION TREATMENTS
NEW UNDERSTANDING OF 'SUPERANTIGENS' COULD LEAD TO IMPROVED STAPH INFECTION TREATMENTS
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

NEW UNDERSTANDING OF 'SUPERANTIGENS' COULD LEAD TO IMPROVED STAPH INFECTION TREATMENTS

States News Service, 2022-07-21

States News Service

Sem texto completo

Citações Citado por
4
Answering the Challenges Posed by Antimicrobial Resistance
Answering the Challenges Posed by Antimicrobial Resistance
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Answering the Challenges Posed by Antimicrobial Resistance

allAfrica.com (English), 2022-09-30

AllAfrica Global Media

Sem texto completo

Citações Citado por
5
Answering the Challenges Posed By Antimicrobial Resistance
Answering the Challenges Posed By Antimicrobial Resistance
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Answering the Challenges Posed By Antimicrobial Resistance

allAfrica.com (English), 2022-09-21

AllAfrica Global Media

Sem texto completo

Citações Citado por
6
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial

PR newswire, 2022-09-06

PR Newswire Association LLC

Sem texto completo

Citações Citado por
7
Giants scrub locker room after Daniel Fells diagnosed with MRSA
Giants scrub locker room after Daniel Fells diagnosed with MRSA
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Giants scrub locker room after Daniel Fells diagnosed with MRSA

Washingtonpost.com, 2015-10-07

The Washington Post

Sem texto completo

Citações Citado por
8
PHARMACIST-LED NASAL SCREENING SERVICES CUT VANCOMYCIN USE
PHARMACIST-LED NASAL SCREENING SERVICES CUT VANCOMYCIN USE
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

PHARMACIST-LED NASAL SCREENING SERVICES CUT VANCOMYCIN USE

States News Service, 2022-04-04

States News Service

Sem texto completo

Citações Citado por
9
Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, Lipoglycopeptide
Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, Lipoglycopeptide
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, Lipoglycopeptide

PR newswire, 2023-09-08

PR Newswire Association LLC

Sem texto completo

Citações Citado por
10
IMMUNE BOOST MAY PROTECT AGAINST MULTIPLE HOSPITAL-ACQUIRED INFECTIONS
IMMUNE BOOST MAY PROTECT AGAINST MULTIPLE HOSPITAL-ACQUIRED INFECTIONS
Material Type:
Artigo de Jornal 		Adicionar ao Meu Espaço

IMMUNE BOOST MAY PROTECT AGAINST MULTIPLE HOSPITAL-ACQUIRED INFECTIONS

States News Service, 2023-10-31

States News Service

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2008  (4)
  2. 2008Até2011  (56)
  3. 2012Até2014  (70)
  4. 2015Até2018  (94)
  5. Após 2018  (90)
  6. Mais opções open sub menu

Base de Dados/Biblioteca 

  1. Academic OneFile  (313)
  2. Regional Business News  (92)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.